Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
10 | 129702676 | intron variant | G/C | snv | 0.38 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
0.732 | 0.200 | 10 | 129467281 | synonymous variant | C/T | snv | 5.5E-02 | 5.1E-02 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.732 | 0.200 | 10 | 129467281 | synonymous variant | C/T | snv | 5.5E-02 | 5.1E-02 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
|
1.000 | 0.040 | 10 | 129650500 | intron variant | G/A | snv | 0.36 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
10 | 129642165 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
10 | 129627758 | intron variant | T/C | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.120 | 10 | 129683009 | intron variant | C/A;T | snv |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 10 | 129683009 | intron variant | C/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2005 | 2018 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||||
|
0.653 | 0.480 | 10 | 129766800 | missense variant | A/G | snv | 9.3E-02 | 8.7E-02 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2009 | 2013 | ||||||
|
0.653 | 0.480 | 10 | 129766800 | missense variant | A/G | snv | 9.3E-02 | 8.7E-02 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2009 | 2013 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2006 | 2014 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
0.030 | 1.000 | 3 | 2006 | 2014 | |||||||
|
0.732 | 0.200 | 10 | 129467281 | synonymous variant | C/T | snv | 5.5E-02 | 5.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2009 | 2016 | ||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2008 | 2012 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||||
|
0.763 | 0.200 | 10 | 129766957 | missense variant | C/T | snv | 2.0E-05 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||||
|
0.605 | 0.480 | 10 | 129708019 | missense variant | C/T | snv | 0.14 | 0.14 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2010 |